151 related articles for article (PubMed ID: 27761927)
1. Hypercalcaemia-induced kidney injury caused by the vitamin D analogue calcitriol for psoriasis: a note of caution when prescribing topical treatment.
Corden E; Higgins E; Smith C
Clin Exp Dermatol; 2016 Dec; 41(8):899-901. PubMed ID: 27761927
[TBL] [Abstract][Full Text] [Related]
2. Topical treatment with 22-oxacalcitriol (OCT), a new vitamin D analogue, caused severe hypercalcemia with exacerbation of chronic renal failure in a psoriatic patient with diabetic nephropathy; a case report and analysis of the potential for hypercalcemia.
Ohigashi S; Tatsuno I; Uchida D; Higurashi M; Hoshimoto S; Seki N; Hashimoto N; Saito Y
Intern Med; 2003 Dec; 42(12):1202-5. PubMed ID: 14714959
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcaemia and hypercalciuria after topical treatment of psoriasis with excessive amounts of calcipotriol.
Georgiou S; Tsambaos D
Acta Derm Venereol; 1999 Jan; 79(1):86. PubMed ID: 10086871
[No Abstract] [Full Text] [Related]
4. Hypercalcaemia with topical calcipotriol.
Bourke JF; Berth-Jones J; Hutchinson PE
BMJ; 1993 May; 306(6888):1344-5. PubMed ID: 8518595
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
Kircik L
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment.
Braun GS; Witt M; Mayer V; Schmid H
Int J Dermatol; 2007 Dec; 46(12):1315-7. PubMed ID: 18173537
[No Abstract] [Full Text] [Related]
7. Vitamine D analogue-based therapies for psoriasis.
O'Neill JL; Feldman SR
Drugs Today (Barc); 2010 May; 46(5):351-60. PubMed ID: 20517536
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
Abramovits W
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
[TBL] [Abstract][Full Text] [Related]
9. [Combined topical therapy of psoriasis: position of calcitriol and vitamin D analogs].
Schmitt J; Meurer M
Hautarzt; 2006 Aug; 57(8):679-84. PubMed ID: 16865352
[TBL] [Abstract][Full Text] [Related]
10. Patterns of vitamin D analog use for the treatment of psoriasis.
Ahn CS; Awadalla F; Huang KE; Yentzer B; Dabade TS; Feldman SR
J Drugs Dermatol; 2013 Aug; 12(8):906-10. PubMed ID: 23986164
[TBL] [Abstract][Full Text] [Related]
11. [Topical treatment of psoriasis with calcipotriol. Report of clinical experience].
Hofmann C; Schirle S
Fortschr Med; 1993 Dec; 111(35-36):562-4. PubMed ID: 8307546
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
Lahfa M; Mrowietz U; Koenig M; Simon JC
Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
[TBL] [Abstract][Full Text] [Related]
13. Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy.
Gorgievska Sukarovska B; Lipozencić J
Acta Dermatovenerol Croat; 2006; 14(3):188-96. PubMed ID: 17010269
[TBL] [Abstract][Full Text] [Related]
14. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis.
Langner A; Ashton P; Van De Kerkhof PC; Verjans H
Br J Dermatol; 1996 Sep; 135(3):385-9. PubMed ID: 8949430
[TBL] [Abstract][Full Text] [Related]
15. Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study.
Langner A; Verjans H; Stapór V; Mol M; Fraczykowska M
Br J Dermatol; 1993 May; 128(5):566-71. PubMed ID: 8504051
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcaemic crisis after excessive topical use of a vitamin D derivative.
Hoeck HC; Laurberg G; Laurberg P
J Intern Med; 1994 Mar; 235(3):281-2. PubMed ID: 8120527
[TBL] [Abstract][Full Text] [Related]
17. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
Thiers BH
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
[TBL] [Abstract][Full Text] [Related]
18. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
19. Calcitriol ointment: optimizing psoriasis therapy.
Gold LF
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s23-7. PubMed ID: 19702033
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D analogues in psoriasis: effects on systemic calcium homeostasis.
Bourke JF; Iqbal SJ; Hutchinson PE
Br J Dermatol; 1996 Sep; 135(3):347-54. PubMed ID: 8949424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
